International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 14 , ISSUE 1 ( January-April, 2023 ) > List of Articles


Intrauterine Infusion of Leukocyte Platelet-rich Plasma Enhances Fertility Outcomes in the Murine Model of Asherman's Syndrome

Hoang Minh Lam, Tuyet Thi Vi Le, Ha Le Bao Tran

Keywords : Asherman's syndrome, Damaged endometrium, Leukocyte platelet-rich plasma, Mouse model, Tissue regeneration

Citation Information : Lam HM, Le TT, Tran HL. Intrauterine Infusion of Leukocyte Platelet-rich Plasma Enhances Fertility Outcomes in the Murine Model of Asherman's Syndrome. Int J Infertil Fetal Med 2023; 14 (1):26-30.

DOI: 10.5005/jp-journals-10016-1292

License: CC BY-NC 4.0

Published Online: 28-04-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Background: Platelet-rich plasma (PRP) contains many platelets and growth factors (GFs) that have been proven to promote wound healing, cell proliferation, and migration. The impact of leukocyte platelet-rich plasma (L-PRP) consequence in the murine model of Asherman's syndrome (AS) is considerable. Aim: To evaluate the effect of one dose of L-PRP in the murine model of AS. Materials and methods: Asherman mouse models were conducted by inserting the 25 gauge needle into the uterine horn through the lumen and stabilized for three estrous cycles. L-PRP (20 µL/horn) was injected into the uterine horn through the vagina of mice at the diestrus of the third estrous cycle. The function of the uterine was recorded at the eighth estrous cycle. Statistical analysis: Data were expressed as mean ± standard deviation (SD). Student's t-test and one-way analysis of variance (ANOVA) were performed by GraphPad 8.0. Results: L-PRP solution increases the number of uterine glands, increases the thickness of the endometrium, and expands the area of uterine lumen in the PRP group after one cycle of estrus. Besides that, using the L-PRP solution increased the rate of pregnancy in the mouse. Conclusion: One dose of L-PRP has a positive impact on improving uterine function in the murine model of AS. Clinical significance: This study provides a scientific basis for the potential application of the one dose-L-PRP in the clinical treatment of endometrial damage.

PDF Share
  1. Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health 2019;11:191–198. DOI: 10.2147/IJWH.S165474
  2. Azizi R, Aghebati-Maleki L, Nouri M, et al. Stem cell therapy in Asherman syndrome and thin endometrium: stem cell-based therapy. Biomed Pharmacother 2018;102:333–343. DOI: 10.1016/j.biopha.2018.03.091
  3. Jang HY, Myoung SM, Choe JM, et al. Effects of autologous platelet-rich plasma on regeneration of damaged endometrium in female rats. Yonsei Med J 2017;58(6):1195–1203. DOI: 10.3349/ymj. 2017.58.6.1195
  4. Kim JH, Park M, Paek JY, et al. Intrauterine infusion of human platelet-rich plasma improves endometrial regeneration and pregnancy outcomes in a murine model of Asherman's syndrome. Front Physiol 2020;11:105. DOI: 10.3389/fphys.2020.00105
  5. Yu D, Wong YM, Cheong Y, et al. Asherman syndrome—one century later. Fertil Steril 2008;89(4):759–779. DOI: 10.1016/j.fertnstert.2008.02.096
  6. Jiang X, Li X, Fei X, et al. Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in Asherman syndrome. Bioactive Mater 2021;6(11):3935–3946. DOI: 10.1016/j.bioactmat.2021.04.006
  7. Liao X, Liang JX, Li SH, et al. Allogeneic platelet-rich plasma therapy as an effective and safe adjuvant method for chronic wounds. J Surg Res 2020;246:284–291. DOI: 10.1016/j.jss.2019.09.019
  8. Hosseini M, Shafiee A. Engineering bioactive scaffolds for skin regeneration. Small 2021;17(41):e2101384. DOI: 10.1002/smll.202101384
  9. Sharun K, Pawde AM, Amarpal. Classification and coding systems for platelet-rich plasma (PRP): a peek into the history. Expert Opin Biol Ther 2021;21(2):121–123. DOI: 10.1080/14712598.2021.1846715
  10. Chou TM, Chang HP, Wang JC. Autologous platelet concentrates in maxillofacial regenerative therapy. Kaohsiung J Med Sci 2020;36(5):305–310. DOI: 10.1002/kjm2.12192
  11. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27(3):158–167. DOI: 10.1016/j.tibtech.2008.11.009
  12. Wilgus TA. Vascular endothelial growth factor and cutaneous scarring. Adv Wound Care 2019;8(12):671–678. DOI: 10.1089/wound.2018.0796
  13. Li B, Zhang Q, Sun J, et al. Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther 2019;10(1):257. DOI: 10.1186/s13287-019-1368-9
  14. Wang X, Ma N, Sun Q, et al. Elevated NF-κB signaling in Asherman syndrome patients and animal models. Oncotarget 2017;8(9):15399–15406. DOI: 10.18632/oncotarget.14853
  15. Zhou Q, Wu X, Hu J, et al. Abnormal expression of fibrosis markers, estrogen receptor α and stromal derived factor–1/chemokine (C-X-C motif) receptor-4 axis in intrauterine adhesions. Int J Mol Med 2018;42(1):81–90. DOI: 10.3892/ijmm.2018.3586
  16. Bazoobandi S, Tanideh N, Rahmanifar F, et al. Preventive effects of intrauterine injection of bone marrow-derived mesenchymal stromal cell-conditioned media on uterine fibrosis immediately after endometrial curettage in rabbit. Stem Cells Int 2020;2020:8849537. DOI: 10.1155/2020/8849537
  17. Bakhsh AS, Maleki N, Sadeghi MR, et al. Effects of autologous platelet-rich plasma in women with repeated implantation failure undergoing assisted reproduction. JBRA Assist Reprod 2022;26(1):84–87. DOI: 10.5935/1518-0557.20210046
  18. Catanzano O, Quaglia F, Boateng JS. Wound dressings as growth factor delivery platforms for chronic wound healing. Expert Opin Drug Deliv 2021;18(6):737–759. DOI: 10.1080/17425247.2021.1867096
  19. Wang SZ, Fan WM, Jia J, et al. Is exclusion of leukocytes from platelet-rich plasma (PRP) a better choice for early intervertebral disc regeneration? Stem Cell Res Ther 2018;9(1):199. DOI: 10.1186/s13287-018-0937-7
  20. Alawadhi F, Du H, Cakmak H, et al. Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome. PLoS ONE 2014;9(5):e96662. DOI: 10.1371/journal.pone.0096662
  21. Kim YY, Choi BB, Lim JW, et al. Efficient production of murine uterine damage model. Tissue Eng Regen Med 2019;16(2):119–129. DOI: 10.1007/s13770-018-0149-3
  22. Zhang S, Tan J, Li P. Co-transplantation of menstrual stromal cell and platelet-rich plasma improves Asherman's syndrome in rat model. Fertil Steril 2017;108(3):E193. DOI: 10.1016/j.fertnstert.2017.07.570
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.